Answers are grounded in this paper and cite their sources.
Universal HBsAg screening of adults in the US general population for CHB is cost-effective and likely cost-saving compared with current CHB screening recommendations.
No takes yet. Share an insight, caveat, or question.
Toy et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: